share_log
Reuters ·  May 9 06:22
Syndax Pharmaceuticals Inc : Guggenheim Cuts Target Price to $35 From $43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment